# The quality and scope of health information on online drug platforms: a topic modelling and expert evaluation study of a Polish-language forum. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/health-information-quality-online-drug-platforms/ > **Published:** 2026-03-26T11:06:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:37:53-04:00 > **Clinical Summary:** Explore health information quality online drug platforms through a study analyzing user-generated content on Polish drug forums and cannabis discussions. --- CED Clinical Relevance  #58Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic CannabisPatient Education[Harm Reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/)Online Health InformationInflammation Journal [Harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/) journal Study Type Clinical Study Population Human participants Why This Matters Online drug forums have become significant sources of health information for cannabis and other substance users, often filling gaps where clinical guidance is limited. Understanding the quality and scope of user-generated content on these platforms reveals how patients actually seek and share therapeutic information outside formal medical settings. Clinical Summary This multimethod study analyzed content from Hyperreal, Poland’s largest drug forum, using topic modeling and expert evaluation to assess health information quality. The semantic analysis revealed specific substance-health topic associations, including marijuana discussions focused on symptom relief and inflammation management. The research employed content scraping and topic distribution analysis to identify the most frequently discussed themes and their clinical relevance. Notable limitations include the study’s focus on a single Polish-language platform and potential selection bias in user-generated content. Dr. Caplan’s Take “This study confirms what I observe clinically—patients are actively seeking and sharing cannabis therapeutic information online when clinical resources are insufficient. The finding that marijuana discussions center on symptom relief and inflammation aligns with the most common patient presentations in my practice.” Clinical Perspective 🧠 Clinicians should recognize that patients likely consult online forums for cannabis information and approach these conversations without judgment. Rather than dismissing online sources, we should help patients critically evaluate the information they encounter and provide evidence-based guidance to complement their research. This study underscores the need for better [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) education resources. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20quality%20and%20scope%20of%20health%20information%20on%20online%20drug%20platforms%3A%20a%20topic%20mo...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41699708/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41699708/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20quality%20and%20scope%20of%20health%20information%20on%20online%20drug%20platforms%3A%20a%20topic%20mo...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41699708/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41699708/](https://pubmed.ncbi.nlm.nih.gov/41699708/) Table of Contents - [FAQ](#FAQ)[Should I trust health information about cannabis found on online drug forums?](#Should_I_trust_health_information_about_cannabis_found_on_online_drug_forums) - [What health topics do cannabis users most commonly discuss on online platforms?](#What_health_topics_do_cannabis_users_most_commonly_discuss_on_online_platforms) - [Can online drug forums be useful for harm reduction strategies?](#Can_online_drug_forums_be_useful_for_harm_reduction_strategies) - [How do patients typically use cannabis for medical purposes based on online discussions?](#How_do_patients_typically_use_cannabis_for_medical_purposes_based_on_online_discussions) - [What should healthcare providers know about patients who seek drug information online?](#What_should_healthcare_providers_know_about_patients_who_seek_drug_information_online) - [Related](#Related) ## FAQ #### Should I trust health information about cannabis found on online drug forums? Online drug forums contain user-generated content that varies significantly in quality and accuracy. While this study found that users discuss legitimate health topics like cannabis for inflammation and symptom relief, the information should be considered anecdotal and not a substitute for professional medical advice. #### What health topics do cannabis users most commonly discuss on online platforms? According to this research, cannabis users frequently discuss symptom relief and [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/). The study’s topic modeling revealed that marijuana discussions were specifically associated with symptom management and inflammation-related health concerns. #### Can online drug forums be useful for harm reduction strategies? Yes, these platforms demonstrate user-driven knowledge construction that could inform harm reduction approaches. The study suggests that understanding how users share health information on these forums can help shape more effective harm reduction strategies by healthcare providers and [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) officials. #### How do patients typically use cannabis for medical purposes based on online discussions? Based on the forum analysis, users primarily discuss cannabis for symptom relief and managing inflammation. However, these represent user experiences rather than evidence-based medical protocols, and patients should consult healthcare providers for proper [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) guidance. #### What should healthcare providers know about patients who seek drug information online? Providers should be aware that patients may be accessing health information from online drug forums where quality varies significantly. Understanding these platforms can help clinicians engage in more informed discussions about substance use and provide evidence-based alternatives to potentially inaccurate online information. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “The quality and scope of health information on online drug platforms: a topic modelling and expert evaluation study of a Polish-language forum.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41699708/”, “about”: “harm reduction journal clinical study quality”, “isPartOf”: “Harm reduction journal”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Unregulated Substance Abuse and Systemic Inflammation Markers: A Review.](https://cedclinic.com/inflammatory-biomarkers-unregulated-substance-use-review/) A comprehensive review of systemic inflammation markers related to unregulated substance abuse, providing context for health discussions on drug platforms. [Read the review](https://cedclinic.com/inflammatory-biomarkers-unregulated-substance-use-review/) [A mixed-methods evaluation of a statewide naloxone distribution project](https://cedclinic.com/opioid-overdose-prevention-naloxone-distribution-evaluation/) Evaluation of opioid overdose prevention initiatives that complements understanding of harm reduction strategies discussed on drug forums. [Explore the evaluation](https://cedclinic.com/opioid-overdose-prevention-naloxone-distribution-evaluation/) [Opioids and Cannabis: An Uncertain Combination?](https://cedclinic.com/opioid-cannabis-interactions-risks-clinical-insights/) An analysis of the complex interactions between opioids and cannabis, relevant to health information shared on online drug platforms. [Learn more](https://cedclinic.com/opioid-cannabis-interactions-risks-clinical-insights/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).